Skip to content

Natera, Inc. NTRA Asia Pacific and Other — Total revenues

Other geography segments

Europe Middle East India And Africa
$24.48M+2.5%
Europe, Middle East, India, Africa
$6.43M+6.2%
Americas, excluding U.S.
$2.4M

Similar metrics at other companies

ServiceNow logo
NOWAsia Pacific and other — Total revenues
$432M+25.9%
Cerence Inc. logo
CRNCOther Asia Pacific — Total revenues
$18.09M-25.9%
Ardelyx logo
ARDXAsia Pacific — Total revenues
$7.29M+103%
Arteris, Inc. logo
AIPOther Asia Pacific — Total Revenue
$1.94M+46.2%
Pacific Biosciences of California logo
PACBAsia-Pacific — Total Revenue
$9.72M-16.2%
Maravai LifeSciences Holdings, Inc. logo
MRVIAsia Pacific — Revenue
$7.87M-25.4%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$37.51B+59.8%
Enterprise value$36.66B+61.8%
P/S15×+3.1×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s asia pacific and other — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natera, Inc.'s asia pacific and other — total revenues?
Natera, Inc. (NTRA) reported asia pacific and other — total revenues of $2.22M in Q1 2026.
What does asia pacific and other — total revenues mean?
This metric represents the total revenue generated from diagnostic testing services and research collaborations within the Asia Pacific region and other international markets outside of the company's primary domestic territory. It captures the company's ability to expand its molecular and bioinformatics technology footprint into diverse global healthcare systems. Monitoring this figure helps assess the success of international commercialization strategies and the adoption rate of proprietary genetic testing products in non-core geographic markets.